Novo Nordisk has launched Awiqli, a new weekly basal insulin injection, in India. This innovative drug offers a once-weekly ...

Novo Nordisk has launched Awiqli, a once-weekly basal insulin, in India. This innovation offers a significant reduction from ...

Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

India has become one of the first countries to introduce Awiqli, the world’s first once-weekly basal insulin for adults with ...

A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for ...

By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...

Novo Nordisk has introduced Awiqli (insulin icodec) in India, the world's first once-weekly basal insulin, reducing annual ...

The launch marks a major step in diabetes care, as patients who currently require one basal insulin injection every day may ...

Novo Nordisk India is rolling out Awiqli – a weekly once basal insulin, for adults with Type 1 or Type 2 diabetes mellitus.

Dr. Marie McDonnell, the director of the Brigham Diabetes Program at Brigham and Women’s Hospital in Boston, told TODAY that basal insulin is a long-acting insulin therapy that helps the body process ...

One injection a week instead of one every day. Danish drugmaker Novo Nordisk has launched Awiqli, or insulin icodec, in India ...

Novo Nordisk has launched Awiqli, the world's first once-weekly basal insulin, in India. The therapy is aimed at easing ...